On April 20, 2017, an inspection notification was received from Chinese office of FDA (United States Food and Drug Administration) by our company. It stated that FDA would perform an on-site inspection to Southwest No.2 Pharmaceutical Factory Co., Ltd. on April 25-28. Under the time pressure, our company quickly communicated with the factory and organized an audit team. A timely and effective improvement for the factory’s quality system was made, all the quality risks were controlled in a short time, a perfect plan for this audit was properly established. Through our company’s hard work and the factory’s active preparation, we passed this flight inspection successfully.